Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Accountprinceon Mar 06, 2023 1:14pm
159 Views
Post# 35321714

RE:RE:RE:RE:Update on Dialco Deal with Infomed?

RE:RE:RE:RE:Update on Dialco Deal with Infomed?hmmmmm.  Blair told Eazeetrader in an email that he didn't care what any current shareholder thinks?  That is a bombshell.  I would think that you'd include that with the submission to the regulator.

Again - how have they reacted?  Kindly bring us up to date on what's transpired with the OSC.  Also the BOD.  And if Eazeetrader has the email from management please share it with the rest of us.  It's significant enough to be brought up at the upcoming AGM.  Along with the need for full disclosure of the Infomed deal.
<< Previous
Bullboard Posts
Next >>